M&A

M&A

SeQuent Scientific acquires Brazil-based animal drug firm Nourrie for $5-M

Business Standard  

Carlyle-backed SeQuent Scientific has announced that Alivira Sae Animal, Brazil, a wholly owned subsidiary of the company, has completed the acquisition of 100% stake in Nourrie Sae e Nutrio Animal. With this acquisition, Nourrie has become a wholly owned subsidiary of Alivira Sae Animal and consequently of the company. The acquisition was made for BRL 27 million (USD 5 million). SeQuent had originally announced signing of the binding agreement to acquire Nourrie on 16 December 2021. The conclusion of Nourrie's acquisition marks an important milestone in Sequent's strategy of establishing presence in Brazil's pet market.